Cullinan Associates’s AB InBev BUD Stock Holding History

Cullinan Associates’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-46,538	Closed	-$4.08M	–	182
2018 Q3	$4.08M	Buy	46,538 +858	+2%	+$83.6K	0.3%	92
2018 Q2	$4.6M	Buy	+45,680	New	+$4.53M	0.35%	82

Other funds holding BUD

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HMP

HS Management Partners New York $286M AUM 2.97% 1-Year Est. Return

Cullinan Associates's BUD Position: Q4 2018 in Review

Cullinan Associates sold out of AB InBev (BUD) in Q4 2018, closing a stake of 46,538 shares — an estimated $4.08M sold.

Cullinan Associates first reported a position in BUD in Q2 2018 and held it in 2 quarters. The position peaked at $4.6M in Q2 2018. 513 funds tracked by Wall St. Rank hold BUD as of Q4 2018.

Cullinan Associates reported no remaining AB InBev position as of Q4 2018 after selling out during the quarter.
Cullinan Associates sold 46,538 AB InBev shares in Q4 2018, an estimated $4.08M.
Cullinan Associates first reported a position in AB InBev in Q2 2018 and held it in 2 quarters.
Cullinan Associates's AB InBev position peaked at $4.6M in Q2 2018.
513 funds tracked by Wall St. Rank held AB InBev as of Q4 2018.

Based on Cullinan Associates's 13F filing for Q4 2018, filed 11 Jan 2019.